About Chiesi USA (NASDAQ:CRTX)
Cornerstone Therapeutics Inc. is a specialty pharmaceutical company focused on commercializing products for the hospital, respiratory and related specialty markets. The Company's promoted products include CUROSURF, ZYFLO CR, FACTIVE and SPECTRACEF. On December 30, 2011, the Company acquired Cardiokine, Inc., a specialty pharmaceutical company, focused on developing hospital products for cardiovascular indications. In March 2012, it acquired the North American product rights for FACTIVE (Gemifloxacin Mesylate) tablets. In June 2012, the Company acquired EKR Therapeutics, Inc. In February 2014, Chiesi Farmaceutici S.p.A acquired Cornerstone Therapeutics Inc.
Industry, Sector and Symbol
Industry N/A
Sub-IndustryPharmaceuticals
SectorN/A
SymbolNASDAQ:CRTX
CUSIP21924P10
Phone+1-919-6786611
Debt
Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A
Profitability
EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A
Miscellaneous
EmployeesN/A
Outstanding SharesN/A
Chiesi USA (NASDAQ:CRTX) Frequently Asked Questions
What is Chiesi USA's stock symbol?
Chiesi USA trades on the NASDAQ under the ticker symbol "CRTX."
Who are Chiesi USA's key executives?
Chiesi USA's management team includes the folowing people:
- Kenneth R. McBean, President (Age 48)
- Craig Alexander Collard, Chief Executive Officer
- Alastair S. McEwan, Chief Financial Officer, Treasurer, Secretary (Age 62)
- Andreas Maetzel, Vice President - Clinical and Regulatory (Age 50)
- Alan T. Roberts, Vice President - Scientific Affairs (Age 47)
- Joshua B. Franklin, Vice President - Strategy and Business Development (Age 44)
- Ugo Di Francesco, Director
Has Chiesi USA been receiving favorable news coverage?
News headlines about CRTX stock have trended positive this week, Accern reports. The research group identifies negative and positive news coverage by monitoring more than twenty million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Chiesi USA earned a coverage optimism score of 0.29 on Accern's scale. They also assigned news articles about the specialty pharmaceutical company an impact score of 45.18 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the company's share price in the next few days.
How do I buy shares of Chiesi USA?
Shares of CRTX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How can I contact Chiesi USA?
Chiesi USA's mailing address is 1255 Crescent Grn Ste 250, CARY, NC 27518-8128, United States. The specialty pharmaceutical company can be reached via phone at +1-919-6786611.
MarketBeat Community Rating for Chiesi USA (CRTX)
MarketBeat's community ratings are surveys of what our community members think about Chiesi USA and other stocks. Vote "Outperform" if you believe CRTX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CRTX will underperform the S&P 500 over the long term. You may vote once every thirty days.
Chiesi USA (NASDAQ:CRTX) Analyst Ratings History
| Date | Brokerage | Action | Rating | Price Target | Impact on Share Price | Details |
|---|
(Data available from 4/25/2016 forward)
Chiesi USA (NASDAQ:CRTX) Earnings History and Estimates Chart
Chiesi USA (NASDAQ CRTX) Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Actual EPS | Revenue Estimate | Actual Revenue | Release Link | Conference Call | Details |
|---|
| 11/7/2013 | Q3 2013 | | $0.45 | | $53.70 million | View | N/A |  |
| 8/6/2013 | Q2 2013 | $0.12 | $0.19 | $35.79 million | $40.40 million | View | N/A | |
| 5/9/2013 | Q1 2013 | | $0.22 | $35.40 million | $37.98 million | View | N/A | |
| 3/14/2013 | Q4 2012 | $0.30 | $0.20 | | | View | N/A | |
| 11/8/2012 | Q312 | $0.32 | $0.19 | $32.00 million | $37.50 million | View | N/A | |
| 8/9/2012 | Q2 2012 | ($0.04) | $0.08 | | | View | N/A | |
| 5/15/2012 | Q1 2012 | $0.08 | ($0.08) | | | View | N/A | |
| 3/8/2012 | Q4 2011 | ($0.02) | ($0.06) | | | View | N/A | |
| 11/3/2011 | | $0.02 | $0.13 | | | View | N/A | |
| 8/4/2011 | | $0.06 | $0.11 | | | View | N/A | |
| 5/12/2011 | | $0.15 | $0.17 | | | View | N/A | |
| 3/3/2011 | | $0.12 | $0.20 | | | View | N/A | |
| 11/4/2010 | Q3 2010 | $0.03 | $0.14 | | | View | N/A | |
| 8/5/2010 | Q2 2010 | $0.11 | $0.08 | | | View | N/A | |
| 5/4/2010 | Q1 2010 | $0.15 | $0.27 | | | View | N/A | |
| 3/4/2010 | Q4 2009 | ($0.04) | $0.19 | | | View | N/A | |
| 11/4/2009 | Q3 2009 | $0.01 | $0.06 | | | View | N/A | |
| 8/11/2009 | Q2 2009 | $0.33 | $0.13 | | | View | N/A | |
| 5/7/2009 | Q1 2009 | $0.17 | $0.48 | | | View | N/A | |
| 3/26/2009 | Q4 2008 | $0.13 | $1.03 | | | View | N/A | |
| 10/20/2008 | Q3 2008 | ($1.00) | ($0.46) | | | View | N/A | |
| 8/11/2008 | Q2 2008 | ($2.50) | ($1.34) | | | View | N/A | |
| 5/8/2008 | Q1 2008 | ($2.30) | ($2.52) | | | View | N/A | |
| 3/27/2008 | Q4 2007 | ($2.30) | ($2.71) | | | View | N/A | |
(Earnings results data provided by Zacks Investment Research)
Chiesi USA (NASDAQ:CRTX) Dividend History by Quarter
| Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
|---|
(Data available from 1/1/2013 forward)
Chiesi USA (NASDAQ CRTX) Insider Trading and Institutional Ownership History
Chiesi USA (NASDAQ CRTX) Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
| 2/3/2014 | Farmaceutici Spa Chiesi | Major Shareholder | Buy | 11,542,313 | $9.50 | $109,651,973.50 | | |
(Data available from 1/1/2013 forward)
Chiesi USA (NASDAQ CRTX) News Headlines
| Source: |
|
No headlines for this company have been tracked by MarketBeat.com
Chiesi USA (NASDAQ:CRTX) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Chiesi USA (NASDAQ:CRTX) Income Statement, Balance Sheet and Cash Flow Statement
Chiesi USA (NASDAQ CRTX) Stock Chart for Wednesday, April, 25, 2018
Loading chart…
